An Investigation of Epidemic Enterovirus 71 Infection in Taiwan, 2008-Reference-Cited by-同舟云学术

An Investigation of Epidemic Enterovirus 71 Infection in Taiwan, 2008

Published:2010-11 Issue:11 Volume:29 Page:1030-1034
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Lee Min-Shi,Lin Tzou-Yien,Chiang Pai-Shan,Li Wen-Chen,Luo Shu-Ting,Tsao Kuo-Chien,Liou Guan-Yuan,Huang Mei-Liang,Hsia Shao-Hsuan,Huang Yhu-Chering,Chang Shih-Cheng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference36 articles.

1. Genetic evolution of enterovirus 71: epidemiological and pathological implications.;Bible;Rev Med Virol,2007

2. An apparently new enterovirus isolated from patients with disease of the central nervous system.;Schmidt;J Infect Dis,1974

3. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children.;Huang;Pediatrics,2006

4. Neurodevelopment and cognition in children after enterovirus 71 infection.;Chang;N Engl J Med,2007

5. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71.;Shindarov;J Hyg Epidemiol Microbiol Immunol,1979

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoproteomics enables identification of coatomer subunit zeta‐1 targeted by a small molecule for enterovirus A71 inhibition;MedComm;2024-06

2. CHAT: Accurate Network Latency Measurement for 5G E2E Networks;IEEE/ACM Transactions on Networking;2023-12

3. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups;Journal of General Virology;2023-11-01

4. Enteroviruses and Parechoviruses;Principles and Practice of Pediatric Infectious Diseases;2023

5. Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial;Vaccine;2022-08